Qinghong Han

2.9k total citations
111 papers, 2.1k citations indexed

About

Qinghong Han is a scholar working on Biotechnology, Genetics and Oncology. According to data from OpenAlex, Qinghong Han has authored 111 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Biotechnology, 61 papers in Genetics and 35 papers in Oncology. Recurrent topics in Qinghong Han's work include Cancer Research and Treatments (101 papers), Virus-based gene therapy research (59 papers) and Cancer, Hypoxia, and Metabolism (27 papers). Qinghong Han is often cited by papers focused on Cancer Research and Treatments (101 papers), Virus-based gene therapy research (59 papers) and Cancer, Hypoxia, and Metabolism (27 papers). Qinghong Han collaborates with scholars based in United States, Japan and South Korea. Qinghong Han's co-authors include Robert M. Hoffman, Yuying Tan, Michael Bouvet, Jun Yamamoto, Shukuan Li, YUSUKE AOKI, Kentaro Miyake, Yutaro Kubota, Kazuyuki Hamada and Norihiko Sugisawa and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Nature Protocols.

In The Last Decade

Qinghong Han

100 papers receiving 2.1k citations

Peers

Countries citing papers authored by Qinghong Han

Since Specialization

Citations

This map shows the geographic impact of Qinghong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghong Han more than expected).

Fields of papers citing papers by Qinghong Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghong Han. The network helps show where Qinghong Han may publish in the future.

Co-authorship network of co-authors of Qinghong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghong Han. A scholar is included among the top collaborators of Qinghong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghong Han. Qinghong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Engineered Methioninase-expressing Tumor-targetingSalmonella typhimuriumA1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine 2025 ·Cancer Genomics & Proteomics ·Yutaro Kubota, Ming Zhao, Qinghong Han, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Sei Morinaga, (unknown), (unknown), Michael Bouvet, Koichi Kubota, Takuya Tsunoda, Robert M. Hoffman	1
2	Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells 2024 ·Anticancer Research ·(unknown), Yutaro Kubota, (unknown), Qinghong Han, (unknown), Sei Morinaga, Robert M. Hoffman	9
3	Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time 2024 ·Cancer Genomics & Proteomics ·Sei Morinaga, Qinghong Han, (unknown), Byung Mo Kang, (unknown), Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, (unknown), Shinji Miwa, Kentaro Igarashi, (unknown), Hiroyuki Tsuchiya, (unknown), Robert M. Hoffman	0
4	Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma 2024 ·Anticancer Research ·Sei Morinaga, Qinghong Han, (unknown), Byung Mo Kang, (unknown), Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, (unknown), Kentaro Igarashi, (unknown), (unknown), (unknown), Robert M. Hoffman	1
5	Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts 2024 ·Anticancer Research ·Sei Morinaga, Qinghong Han, Yutaro Kubota, (unknown), Byung Mo Kang, (unknown), Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, (unknown), Shinji Miwa, Kentaro Igarashi, (unknown), Hiroyuki Tsuchiya, Robert M. Hoffman	10
6	Comparison of Cell-death Kinetics of Recombinant Methioninase (rMETase)-treated Cancer and Normal Cells: Only Cancer Cells Undergo Methionine-depletion Catastrophe at Low rMETase Concentrations 2024 ·Anticancer Research ·Byung Mo Kang, Qinghong Han, (unknown), Sei Morinaga, Michael Bouvet, Robert M. Hoffman	1
7	The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression ofC-MYC 2023 ·Cancer Genomics & Proteomics ·YUSUKE AOKI, Yutaro Kubota, Qinghong Han, NORIYUKI MASAKI, Koya Obara, Michael Bouvet, Sant P. Chawla, Yasunori Tome, Kotaro Nishida, Robert M. Hoffman	5
8	Targeting Methionine Addiction of Cancer Cells with Methioninase 2023 ·Biochemistry (Moscow) ·Vadim S. Pokrovsky, (unknown), (unknown), Qinghong Han, Robert M. Hoffman	18
9	Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse model 2023 ·Tissue and Cell ·Kentaro Miyake, Qinghong Han, Takashi Murakami, Tasuku Kiyuna, Kei Kawaguchi, Kentaro Igarashi, Thinzar M. Lwin, (unknown), Jun Yamamoto, Michael Bouvet, (unknown), Robert M. Hoffman	3
10	[ ¹¹ C] Methionine-PET Imaging as a Cancer Biomarker for Methionine Addiction and Sensitivity to Methionine-restriction-based Combination Chemotherapy 2023 ·In Vivo ·Yutaro Kubota, (unknown), Qinghong Han, (unknown), Sei Morinaga, (unknown), Takuya Tsunoda, Robert M. Hoffman	9
11	Methionine restriction of glioma does not induce MGMT and greatly improves temozolomide efficacy in an orthotopic nude-mouse model: A potential curable approach to a clinically-incurable disease 2023 ·Biochemical and Biophysical Research Communications ·Yutaro Kubota, YUSUKE AOKI, NORIYUKI MASAKI, Koya Obara, Kazuyuki Hamada, Qinghong Han, Michael Bouvet, Takuya Tsunoda, Robert M. Hoffman	13
12	Oral-recombinant Methioninase in Combination With Rapamycin Eradicates Osteosarcoma of the Breast in a Patient-derived Orthotopic Xenograft Mouse Model 2022 ·Anticancer Research ·NORIYUKI MASAKI, Qinghong Han, (unknown), (unknown), (unknown), Justin C. Wu, Koya Obara, Yutaro Kubota, YUSUKE AOKI, Michael Bouvet, Robert M. Hoffman	12
13	Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model 2021 ·Anticancer Research ·YUSUKE AOKI, Yasunori Tome, (unknown), Jun Yamamoto, Kazuyuki Hamada, Qinghong Han, Michael Bouvet, Kotaro Nishida, Robert M. Hoffman	23
14	Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model 2020 ·Cancer Letters ·Jun Yamamoto, Kentaro Miyake, Qinghong Han, Yuying Tan, Sachiko Inubushi, Norihiko Sugisawa, Takashi Higuchi, Yoshihiko Tashiro, Hiroto Nishino, Yuki Homma, Ryusei Matsuyama, Sant P. Chawla, Michael Bouvet, Shree Ram Singh, Itaru Endo, Robert M. Hoffman	32
15	Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse model 2019 ·Biochemical and Biophysical Research Communications ·Takashi Higuchi, Qinghong Han, Kentaro Miyake, Hiromichi Oshiro, Norihiko Sugisawa, Yuying Tan, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	26
16	The combination of oral-recombinant methioninase and azacitidine arrests a chemotherapy-resistant osteosarcoma patient-derived orthotopic xenograft mouse model 2019 ·Cancer Chemotherapy and Pharmacology ·Takashi Higuchi, Norihiko Sugisawa, Jun Yamamoto, Hiromichi Oshiro, Qinghong Han, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Yuying Tan, Suresh V. Kuchipudi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman	37
17	Efficacy of oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil on primary colon cancer in a patient-derived orthotopic xenograft mouse model 2019 ·Biochemical and Biophysical Research Communications ·Jun Ho Park, Ming Zhao, Qinghong Han, Yu Sun, Takashi Higuchi, Norihiko Sugisawa, Jun Yamamoto, Shree Ram Singh, Bryan M. Clary, Michael Bouvet, Robert M. Hoffman	34
18	Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model 2019 ·Anticancer Research ·Hiromichi Oshiro, Yasunori Tome, Tasuku Kiyuna, Sang Nam Yoon, Thinzar M. Lwin, Qinghong Han, Yuying Tan, Kentaro Miyake, Takashi Higuchi, Norihiko Sugisawa, Yuki Katsuya, Jun Ho Park, (unknown), Sahar Razmjooei, Michael Bouvet, Bryan M. Clary, Shree Ram Singh, Fuminori Kanaya, Kotaro Nishida, Robert M. Hoffman	43
19	Development of Recombinant Methioninase for Cancer Treatment 2019 ·Methods in molecular biology ·Robert M. Hoffman, Yuying Tan, Shukuan Li, Qinghong Han, Shigeo Yagi, Tomoaki Takakura, Akio Takimoto, Kenji Inagaki, (unknown)	11
20	Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer 2018 ·Cancer Letters ·Kei Kawaguchi, Kentaro Miyake, Qinghong Han, Shukuan Li, Yuying Tan, Kentaro Igarashi, Tasuku Kiyuna, Masuyo Miyake, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Sintawat Wangsiricharoen, Michael Bouvet, Shree Ram Singh, Michiaki Unno, Robert M. Hoffman	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact